Multi-Stakeholder Consultation Q1 2019 - Summary Report
During the first quarter of 2019, stakeholder consultations were held over the course of several weeks. The aim of these discussions was to assess wheter the Beyond Animal Testing Index could have added value in the transition to animal free innovation.
This document gives a summary of the usefull and interesting feedback the Index received during the consultations as well as the conclusions the Index has drawn from this feedback.
Abstract
During the first quarter of 2019, stakeholder consultations were held over the course of several weeks. The aim of these discussions was to assess wheter the Beyond Animal Testing Index could have added value in the transition to animal free innovation.
The Beyond Animal Testing Index carefully selected stakeholders associated with the Transition to Animal Free Innovation, which include ZonMW, NWO, NFU, VSNU, SGF and Proefdiervrij.
As opposed to what is stated in the Background Document, stakeholder consultations were only held in an individual setting and not in multi-stakeholder setting.
The first round of stakeholder consultations has been productive and valuable. The following choises have been made with the feedback of the stakeholders in mind:
1. The Index will only focus on awarding organisations for their accomplishments as opposed to penalizing for failures.
2. For its first version, the Index will try to not be too complex, making sure the criteria used can be found in existing documents.
3. In addition to the aforementioned criteria, the Index will include narratives, which will not be used in the raking, but are merely examples of positive organisation efforts and performance.
Furthermore, the Index will make changes to the description of its vision, mission and goals, focussing more on praising (animal free) innovation and less on denouncing animal testing. On this subject, the goal ‘animal welfare’ will be changed in ‘quality’ to include more aspects in addition to animal welfare.
Additionally, the Index will start with a pilot study within the Leiden University Medical Center (after Indicators for all Technical Area’s have been formulated) to assess its feasibility.